The stockpile contains more than $7 billion worth of medicines and medical supplies referred to as the formulary. The Public Health Emergency Medical Countermeasures Enterprise collaborates to determine which items to include based on specific threats to the United States, including the medical vulnerability of U.S. civilians and other factors. The group reviews the stockpile’s formulary annually and makes recommendations regarding changes based on current scientific evidence about future procurements. Organized for flexible response, the stockpile is structured in four categories: Managed Inventory, 12-hour Push Package, CHEMPACK and Federal Medical Stations.
Stockpiled products include:
- Chemical antidotes
- Antiviral drugs
- Personal protective equipment
- Other medical supplies
While many items included in the stockpile formulary are readily available, some are not available in the marketplace. To provide these items, the Biomedical Advanced Research and Development Authority helps develop new medical countermeasures―medicine and medical supplies that can prevent or treat diseases related to a public health emergency―to treat specific disease conditions. With access to these, the stockpile can respond to:
- Bacterial and viral diseases
- Pandemic influenza
- Radiation/nuclear emergencies
- Chemical attacks
- Natural disasters
Why Do We Stockpile Materials?
- A product required to treat a specific disease or condition is not available to the general public.
- A product may not be available in the timeframe in which it is needed.
- A product may not be available in the projected amount required.
- Page last reviewed: April 24, 2017
- Page last updated: April 24, 2017
- Content source: